Search Results - "Montesino, Marlene"
-
1
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause
Published in Menopause (New York, N.Y.) (01-03-2016)“…The aim of this study is to confirm the local beneficial effects of intravaginal dehydroepiandrosterone (DHEA, Prasterone) on moderate to severe dyspareunia or…”
Get full text
Journal Article -
2
Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause
Published in Menopause (New York, N.Y.) (01-11-2017)“…OBJECTIVE:To analyze the effects of intravaginal prasterone obtained in the three randomized clinical studies performed in postmenopausal women suffering from…”
Get full text
Journal Article -
3
-
4
Comparison of intravaginal 6.5 mg (0.50%) prasterone, 0.3 mg conjugated estrogens and 10 µg estradiol on symptoms of vulvovaginal atrophy
Published in The Journal of steroid biochemistry and molecular biology (01-11-2017)“…The objective is to compare the effect of intravaginal dehydroepiandrosterone (DHEA, prasterone), conjugated equine estrogens (CEE) and estradiol (E2) on…”
Get full text
Journal Article -
5
-
6
Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10μg estradiol on symptoms of vulvovaginal atrophy
Published in The Journal of steroid biochemistry and molecular biology (01-11-2017)“…•Intravaginal prasterone was compared with data available from estrogen preparations.•Severity of dyspareunia or dryness was similarly reduced when compared to…”
Get full text
Journal Article -
7
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause
Published in Menopause (New York, N.Y.) (01-11-2018)“…The aim of this study is to confirm the local beneficial effects of intravaginal dehydroepiandrosterone (DHEA, Prasterone) on moderate to severe dyspareunia or…”
Get full text
Journal Article -
8
Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy
Published in Journal of sexual medicine (01-12-2015)“…Previous data have shown that intravaginal dehydroepiandrosterone (DHEA, prasterone) improved all the domains of sexual function, an effect most likely related…”
Get full text
Journal Article -
9
Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration
Published in The Journal of steroid biochemistry and molecular biology (01-11-2015)“…•Intravaginal 0.50% DHEA was administered daily for 12 weeks in postmenopausal women with VVA.•Eleven steroids were measured in serum by validated mass…”
Get full text
Journal Article -
10
Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12weeks
Published in The Journal of steroid biochemistry and molecular biology (01-05-2016)“…•Intravaginal 0.50% (6.5mg) DHEA (prasterone) was administered daily for 12weeks in postmenopausal women with VVA symptoms (n=723, prasterone; n=266, placebo)…”
Get full text
Journal Article -
11
Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator
Published in Gynecological endocrinology (03-03-2016)“…The objective of the study is to evaluate the acceptability of the intravaginal administration of ovules/suppositories of DHEA (dehydroepiandrosterone,…”
Get full text
Journal Article -
12
Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks
Published in The Journal of steroid biochemistry and molecular biology (01-05-2016)“…This study integrates all data obtained in women aged 40-80years enrolled with moderate to severe symptoms of vulvovaginal atrophy (VVA) who received daily…”
Get full text
Journal Article -
13
Assessment of inflammation in large arteries with 18F-FDG-PET in elderly
Published in Computerized medical imaging and graphics (01-10-2013)“…Abstract This paper presents repeated measurements of atherosclerosis using bimodality positron emission tomography and computed tomography (PET/CT) with…”
Get full text
Journal Article -
14
Positron emission tomography imaging for vascular inflammation evaluation in elderly subjects with different risk factors for cardiovascular diseases
Published in American journal of nuclear medicine and molecular imaging (01-01-2014)“…This study was aimed to investigate the usefulness of (18)F-FDG-PET to differentiate vascular inflammation and to determine the effect of rosuvastatin. Eight…”
Get full text
Journal Article -
15
Caractérisation de l'inflammation artérielle associée au vieillissement par la tomographie d'émission par positrons (TEP)
Published 01-01-2013“…L'athérosclérose est une maladie progressive qui peut débuter durant l'enfance et s'aggraver en vieillissant. De nos jours, les chercheurs ne l'étudient plus…”
Get full text
Dissertation